Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

BACKGROUND: Glioma is the most common highly aggressive, primary adult brain tumour. Clinical data show that therapeutic approaches cannot reach the expectations in patients, thus gliomas are mainly incurable diseases. Tumour cells can adapt rapidly to alterations during therapeutic treatments relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Petővári, Gábor, Hujber, Zoltán, Krencz, Ildikó, Dankó, Titanilla, Nagy, Noémi, Tóth, Fanni, Raffay, Regina, Mészáros, Katalin, Rajnai, Hajnalka, Vetlényi, Enikő, Takács-Vellai, Krisztina, Jeney, András, Sebestyén, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300020/
https://www.ncbi.nlm.nih.gov/pubmed/30574020
http://dx.doi.org/10.1186/s12935-018-0710-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300020/
https://www.ncbi.nlm.nih.gov/pubmed/30574020
http://dx.doi.org/10.1186/s12935-018-0710-0

Ejemplares similares